DXCM - DexCom, Inc. So'nggi Yangiliklar | Finranks

05.05.2026

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

05.05.2026

3 Reasons Analysts Love DexCom

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a crucial component of a broader set of tools to address type 2 diabetes. With about 40 million people in the United States suffering from diabetes, and incidents of type 2 diabetes rising across multiple demographics, this core function of this class of medicines is still just as relevant as it was when these drugs first became available.

05.05.2026

Dexcom to Host Investor Day on May 14, 2026

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14, 2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT). The event will include presentations from Dexcom management highlighting the company's market opportunities, business strategy, innovation efforts, and long-term financial outlook. Links to a live webcast of the event will be available on the Dexcom Investor Relations website at investors.dexcom.c.

01.05.2026

DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise

DXCM stock jumps on Q1 beat as revenues rise 15% and margins expand, with strong CGM demand and raised profitability outlook boosting momentum.

01.05.2026

DexCom, Inc. (DXCM) Q1 2026 Earnings Call Transcript

29.04.2026

DXCM or MASI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either DexCom (DXCM) or Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?

29.04.2026

Why DexCom (DXCM) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Videolar

19.02.2026

Positive

The Big 3: VZ, DXCM, AMAT

13.01.2026

Neutral

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
DXCM	Evercore ISI	In-line	undefined >> $68	November 25th 2025
DXCM	Stifel	Buy	undefined >> $85	October 21st 2025
DXCM	Oppenheimer	Perform	undefined >> undefined	September 8th 2025
DXCM	Argus	Buy	undefined >> $100	August 21st 2025
DXCM	Truist	Buy	undefined >> $102	June 16th 2025
DXCM	Goldman	Buy	undefined >> $104	May 30th 2025

Press-relizlar

05.05.2026

DexCom, Inc. (DXCM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

DexCom, Inc. (DXCM)